Jogin H Thakore
Overview
Explore the profile of Jogin H Thakore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
665
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Foxe J, Yeap S, Snyder A, Kelly S, Thakore J, Molholm S
Eur Arch Psychiatry Clin Neurosci
. 2010 Dec;
261(5):331-9.
PMID: 21153832
The N1 component of the auditory evoked potential (AEP) is a robust and easily recorded metric of auditory sensory-perceptual processing. In patients with schizophrenia, a diminution in the amplitude of...
2.
Yeap S, Kelly S, Reilly R, Thakore J, Foxe J
J Psychiatry Neurosci
. 2009 Dec;
34(6):459-64.
PMID: 19949722
Background: Etiological commonalities are apparent between bipolar disorder and schizophrenia. For example, it is becoming clear that both populations show similar electrophysiological deficits in the auditory domain. Recent studies have...
3.
Yeap S, Kelly S, Sehatpour P, Magno E, Garavan H, Thakore J, et al.
Eur Arch Psychiatry Clin Neurosci
. 2008 May;
258(5):305-16.
PMID: 18504634
Context: Visual Evoked Potential (VEP) abnormalities have been a fairly consistent finding in patients with schizophrenia, and it has been suggested that electrophysiological markers of early sensory processing may be...
4.
Yeap S, Kelly S, Thakore J, Foxe J
Schizophr Res
. 2008 May;
102(1-3):340-3.
PMID: 18485671
No abstract available.
5.
Magno E, Yeap S, Thakore J, Garavan H, De Sanctis P, Foxe J
Biol Psychiatry
. 2008 May;
64(5):385-91.
PMID: 18472090
Background: Mismatch negativity (MMN) is a negative-going event-related potential (ERP) component that occurs in response to intermittent changes in constant auditory backgrounds. A consistent finding across a large number of...
6.
Yeap S, Kelly S, Sehatpour P, Magno E, Javitt D, Garavan H, et al.
Arch Gen Psychiatry
. 2006 Nov;
63(11):1180-8.
PMID: 17088498
Context: The imperative to establish so-called endophenotypes-quantifiable measures of risk for neurological dysfunction-is a growing focus of research in schizophrenia. Electrophysiological markers of sensory processing, observable in human event-related potentials,...
7.
Breier A, Berg P, Thakore J, Naber D, Gattaz W, Cavazzoni P, et al.
Am J Psychiatry
. 2005 Oct;
162(10):1879-87.
PMID: 16199834
Objective: The efficacy and safety of olanzapine were compared with those of ziprasidone. Method: This was a multicenter randomized, double-blind, parallel-group, 28-week study of patients with schizophrenia. Patients were randomly...
8.
9.
Walsh P, Spelman L, Sharifi N, Thakore J
Psychoneuroendocrinology
. 2005 Feb;
30(5):431-7.
PMID: 15721055
Dynamic testing of the hypothalamic-pituitary-adrenal axis in schizophrenia has yielded conflicting results, which may be related to patient selection and previous exposure to psychotropic medication. The objective of this study...
10.
Ryan M, Sharifi N, Condren R, Thakore J
Psychoneuroendocrinology
. 2004 Jun;
29(8):1065-70.
PMID: 15219658
Background: Evidence for basal hypothalamic-pituitary-adrenal (HPA) axis dysfunction in schizophrenia is less consistent than that seen in major depression. Potential reasons include sampling procedures and the use of patients on...